Treace Medical Concepts 

$4.43
14
+$0.03+0.68% 20:00 今天

統計

當日最高
4.75
當日最低
4.37
52週高點
7.7
52週低點
1.2
成交量
23,264,074
平均成交量
-
市值
287.39M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

11Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
-0.31
-0.21
-0.11
-0.01
預期EPS
-0.298
實際EPS
不適用

財務

-27.74%利潤率
未盈利
2020
2021
2022
2023
2024
2025
212.69M營收
-59M淨利

分析師評級

7.00平均目標價
最高預估為 7.00。
來自過去6個月內的 1 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 TMCI 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Show more...
執行長
Mr. John T. Treace
員工
450
國家
美國
ISIN
US89455T1097

上市

0 Comments

分享你的想法

FAQ

Treace Medical Concepts 今天的股價是多少?
TMCI 目前價格為 $4.43 USD,過去 24 小時上漲了 +0.68%。在圖表上更密切關注 Treace Medical Concepts 股價表現。
Treace Medical Concepts 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Treace Medical Concepts 的股票以代號 TMCI 進行交易。
Treace Medical Concepts 的股價在上漲嗎?
TMCI 股票較上週下跌 -4.94%,本月上漲 +7.52%,過去一年 Treace Medical Concepts 下跌 -24.27%。
Treace Medical Concepts 的市值是多少?
今天 Treace Medical Concepts 的市值為 287.39M
Treace Medical Concepts 下一次財報日期是什麼時候?
Treace Medical Concepts 將於 August 11, 2026 公布下一次財報。
Treace Medical Concepts 上一季度的財報如何?
TMCI 上一季度的財報為每股 -0.28 USD,預估為 -0.31 USD,帶來 +9.09% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Treace Medical Concepts 去年的營收是多少?
Treace Medical Concepts 去年的營收為 212.69MUSD。
Treace Medical Concepts 去年的淨利是多少?
TMCI 去年的淨收益為 -59MUSD。
Treace Medical Concepts 有多少名員工?
截至 July 16, 2026,公司共有 450 名員工。
Treace Medical Concepts 位於哪個產業?
Treace Medical Concepts從事於Health & Wellness產業。
Treace Medical Concepts 何時完成拆股?
Treace Medical Concepts 最近沒有進行任何拆股。
Treace Medical Concepts 的總部在哪裡?
Treace Medical Concepts 的總部位於 美國 的 Ponte Vedra。